אסיף מאגר המחקר החקלאי

Red grape berry-cultured cells reduce blood pressure in rats with metabolic-like syndrome

Year:

2014

Source of publication :

Authors :

Volume :

53

Co-Authors:

Leibowitz, A., Internal Medicine D and the Hypertension Unit, Chaim Sheba Medical Center, 52621 Tel-Hashomer, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Faltin, Z., Institute of Plant Science, Agricultural Research Organization, Volcani Center, Bet Dagan, Israel
Perl, A., Institute of Plant Science, Agricultural Research Organization, Volcani Center, Bet Dagan, Israel
Eshdat, Y., Institute of Plant Science, Agricultural Research Organization, Volcani Center, Bet Dagan, Israel
Hagay, Y., Fruitura Bioscience, Rehovot, Israel
Peleg, E., Internal Medicine D and the Hypertension Unit, Chaim Sheba Medical Center, 52621 Tel-Hashomer, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Grossman, E., Internal Medicine D and the Hypertension Unit, Chaim Sheba Medical Center, 52621 Tel-Hashomer, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Facilitators :

Link :

Abstract:

Purpose: Cumulative evidence suggests that moderate red wine consumption protects the cardiovascular system. The effect of cultured cells derived from red grape berry (RGC) on blood pressure (BP) has not been investigated. We therefore studied the antihypertensive effects of oral consumption of RGC in experimental rat model of metabolic-like syndrome and assessed its effect on human umbilical vein endothelial cells (HUVECs). Methods: Forty male Sprague-Dawley rats were fed for 5 weeks with either a high fructose diet (HFD) (n = 10) or HFD supplemented, during the last 2 weeks, with different doses (200, 400 and 800 mg/kg/day) of RGC suspended in their food (n = 30). BP, plasma triglycerides, insulin and adiponectin levels were measured at the beginning and after 3 and 5 weeks of diet. RGC effect on vasodilatation was evaluated by its ability to affect endothelin-1 (ET-1) production and endothelial nitric oxide synthase (eNOS) expression in HUVECs. Results: BP, plasma triglycerides, insulin and adiponectin increased significantly in rats fed with a HFD. The increase in BP, plasma triglycerides and insulin was attenuated by RGC supplementation. Incubation of HUVECs with RGC demonstrated a concentration-dependent inhibition of ET-1 secretion and increase in the level of eNOS, signaling a positive effect of RGC on vasodilatation. Conclusion: In rats with metabolic-like syndrome, RGC decreased BP and improved metabolic parameters. These beneficial effects may be mediated by the cell constituents, highly rich with polyphenols and resveratrol, reside in their natural state. © 2013 Springer-Verlag Berlin Heidelberg.

Note:

Related Files :

Related Content

More details

You may also be interested in